The drug is based on a special moleculeScientists from the Federal Research Center (FRC) for Biotechnology of the Russian Academy of Sciences have developed and are conducting preclinical trials of a fundamentally new drug against coronavirus based on a new molecule. Discuss
The molecule is called PDSTP. It has a fundamentally new effect: the molecule interacts not with the virus, but with the host cell, blocking the binding of the virus to the cell and preventing the pathogen from entering the body. Thanks to this, the virus dies.
The optimal form of the drug chosen by the developers is a spray. “Treatment of the upper respiratory mucosa has been shown to prevent infection for at least several hours, and its intraperitoneal use in an animal model provides a powerful therapeutic effect,” the experts said.
Materials of a news nature cannot be equated with a doctor's prescription. Before making a decision, consult with a specialist.
Source: Izvestia